Physician profile
Miteswar Purewal
NPI 1750320461
$19,793.71
in general payments reported to CMS, 2019-2025
28 companies · $1,911 in 2025
The $1,911 reported for 2025 was more than what 81% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,428 · 2020: $1,187 · 2021: $5,358 · 2022: $2,927 · 2023: $1,034 · 2024: $1,949 · 2025: $1,911.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,711 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,710.85 |
| Education | $183.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11,736.90 | 2019-2025 | Proclaim, Octrode, Eterna |
| Vertiflex, INC. | $2,652.58 | 2019 | |
| Nevro Corp. | $1,579.87 | 2019-2024 | Senza |
| Boston Scientific Corporation | $922.52 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Superion Indirect Decompression System |
| Vertos Medical, INC. | $630.94 | 2019-2021 | |
| Curonix LLC | $466.44 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $311.84 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Globus Medical, INC. | $214.38 | 2025 | Senza, Vyrsa V1 |
| Mml US, INC. | $206.31 | 2023-2025 | Reactiv8 |
| Biotronik Nro, INC. | $189.41 | 2025 | Prospera |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $137.58 | 2019-2025 | Relistor |
| Saluda Medical Americas, INC. | $136.22 | 2025 | Evoke |
| Horizon Therapeutics Plc | $118.44 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $92.86 | 2021 | |
| Pacira Therapeutics, INC. | $92.53 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $44.91 | 2019 | |
| Biodelivery Sciences International, INC. | $38.61 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $37.91 | 2019-2020 | |
| Si-Bone, INC. | $31.19 | 2019 | |
| Scilex Pharmaceuticals INC. | $22.08 | 2020 | |
| Fidia Pharma USA INC. | $21.30 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.95 | 2019 | |
| Supernus Pharmaceuticals, INC. | $19.37 | 2019 | |
| Foundation Fusion Solutions, LLC | $17.97 | 2024 | |
| Forte Bio-Pharma LLC | $15.74 | 2019 | |
| Sentynl Therapeutics, INC. | $12.48 | 2019 | |
| West Therapeutics Development, LLC | $11.52 | 2019 | |
| Pfizer INC. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miteswar Purewal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.